Private Capital Management (Florida)’s Ligand Pharmaceuticals LGND Stock Holding History

Private Capital Management (Florida)’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$52.5M	Sell	166,016 -35,365	-18%	-$8.33M	4.62%	4
2026 Q1	$40.2M	Sell	201,381 -7,510	-4%	-$1.49M	4%	7
2025 Q4	$39.5M	Sell	208,891 -18,267	-8%	-$3.51M	3.62%	5
2025 Q3	$40.2M	Sell	227,158 -2,095	-0.9%	-$311K	3.59%	5
2025 Q2	$26.1M	Buy	229,253 +81,128	+55%	+$8.67M	2.52%	16
2025 Q1	$15.5M	Buy	148,125 +14,435	+11%	+$1.63M	1.7%	22
2024 Q4	$14.3M	Sell	133,690 -190	-0.1%	-$21.5K	1.5%	24
2024 Q3	$13.4M	Sell	133,880 -625	-0.5%	-$62.9K	1.44%	23
2024 Q2	$11.3M	Buy	+134,505	New	+$10.7M	1.32%	25

Other funds holding LGND

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Private Capital Management (Florida)'s LGND Position: Q2 2026 in Review

Private Capital Management (Florida) reduced its Ligand Pharmaceuticals (LGND) stake by 18% in Q2 2026, selling an estimated $8.33M and leaving 166,016 shares worth $52.5M. The position accounts for 4.62% of the portfolio, ranked #4.

Private Capital Management (Florida) first reported a position in LGND in Q2 2024 and has held it in 9 quarters since. 416 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

Private Capital Management (Florida) held 166,016 shares of Ligand Pharmaceuticals worth $52.5M as of Q2 2026.
Private Capital Management (Florida) sold 35,365 Ligand Pharmaceuticals shares in Q2 2026, an estimated $8.33M.
Ligand Pharmaceuticals made up 4.62% of Private Capital Management (Florida)'s portfolio in Q2 2026, its #4 holding.
Private Capital Management (Florida) first reported a position in Ligand Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
416 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Private Capital Management (Florida)'s 13F filing for Q2 2026, filed 14 Aug 2026.